Ticker
XFORCompany Name
X4 PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 105.17M | $ -101.98M | -96.96% |
3/31/2025 | $ 130.01M | $ 14.6M | 11.23% |
12/31/2024 | $ 146.45M | $ -37.45M | -25.57% |
9/30/2024 | $ 178.16M | $ -16.76M | -9.41% |
6/30/2024 | $ 210.61M | $ 17.63M | 8.37% |
3/31/2024 | $ 112.18M | $ -128.91M | -114.91% |
12/31/2023 | $ 147.26M | $ -101.17M | -68.7% |
9/30/2023 | $ 173.29M | $ -111.14M | -64.13% |
6/30/2023 | $ 173.4M | $ -130.71M | -75.38% |
3/31/2023 | $ 124.41M | $ -96.21M | -77.34% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for X4 PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -54.57M ] / Assets [ $ 133.13M ]
(=) ROA [ -40.99% ]
Minimum
Jun 30, 2022
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.45K |
---|---|
min | -33.42% |
max | 33.98% |
average | 0.1% |
median | 1.53% |
std | 10.63% |